CRISPR Therapeutics AG

38.31
-0.80 (-2.05%)
At close: Apr 25, 2025, 3:59 PM
38.38
0.18%
After-hours: Apr 25, 2025, 05:54 PM EDT

CRISPR Therapeutics Revenue

CRISPR Therapeutics reported an annual revenue of $35M, reflecting a -90.57% growth. For the quarter ending December 31, 2024, CRISPR Therapeutics generated $35M in revenue.
Revenue (ttm)
$35M
Revenue Growth
-90.57%
Price / Sales Ratio
94.87
Revenue / Employee
$89.06K
Employees
393
Market Cap
3.3B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 35M -90.57%
Dec 31, 2023 371.21M +85038.99%
Dec 31, 2022 436K -99.95%
Dec 31, 2021 913.08M +168054.88%
Dec 31, 2020 543K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.